Presentation by Jonathan Goldstein, Director, Corporate R&D and Venture at Boston Scientific on November 5th, 2020. Covers the historical progression of transformational technological disruption and the opportunities in cardiac devices. These include heart failure products, proctoring in pacemakers as well as Clinical Data and Big Data.